FDA alerted users of Hospira's Symbiq Infusion System that the product has cybersecurity vulnerabilities, and encouraged health care facilities to transition to alternative infusion systems Friday (July 31). This came after FDA started stepping up its cybersecurity efforts, and joined an interagency working group focused on cyber initiatives in December . Also, a few months ago the Senate health committee launched a bipartisan initiative to identify steps Congress can take to help address cyber threats in the health sector, including...